Executive Director Wang Junhong increases shareholding in CHINA LILANG (01234) by 963,000 shares at approximately HK$2.87 per share.
On September 30, Executive Director Wang Junhong increased his shareholding in CHINA LILANG (01234) by 963,000 shares at HK$2.8698 per share, for a total amount of approximately HK$2.7636 million.
The latest information from the Hong Kong Stock Exchange shows that on September 30, Executive Director Wang Junhong increased his shareholding in CHINA LILANG (01234) by 963,000 shares at HK$2.8698 per share, for a total amount of approximately HK$2.7636 million. After the increase, his latest shareholding is 1,835,000 shares, with a latest shareholding ratio of 0.15%.
Related Articles
Lepu Medical Technology (300003.SZ) subsidiary receives U.S. FDA approval for clinical trial of MWN117 injection.
US Stock Market Move | Oil stocks broadly rise; BP p.l.c. Sponsored ADR (BP.US) gains over 3%.
MEGA GENOMICS (06667) repurchased 148,800 shares for HK$1.0691 million on October 8.
Lepu Medical Technology (300003.SZ) subsidiary receives U.S. FDA approval for clinical trial of MWN117 injection.
US Stock Market Move | Oil stocks broadly rise; BP p.l.c. Sponsored ADR (BP.US) gains over 3%.
MEGA GENOMICS (06667) repurchased 148,800 shares for HK$1.0691 million on October 8.
